The life sciences industry relies on technology today more than ever before. Like in many industries, the pandemic pushed teams across pharma to incorporate technologies into their work that may have otherwise taken years to fully incorporate. Today, these technologies have become increasingly commonplace, given the decentralization of everyone involved in drug development—from the study start-up teams to the patient.
